Recipharm and LIDDS establish industrial manufacturing capabilities
Manufacturing line for prostate cancer product set up
21-Jul-2017 -
Recipharm and LIDDS have together set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca®Depot, at Recipharm in Solna, Sweden.
The manufacturing line is dedicated to the first product based on LIDDS’ innovative NanoZolid®technology. Clinical trial material has already been ...
license agreements
pharmaceutical industry
production
+1